A. Carayon's Profile

Role	Title	Level	Year	L/R
🐜	Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. 9 auth. D. Dexter, A. Carayon, F. Javoy‐Agid, Y. Agid, F. R. Wells, S. Daniel, ... A. Lees, P. Jenner, C. Marsden	10	1991	10 🐜
🐜	, Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of 8 auth. J. Silvestre, C. Heymes, Abdeslam Oubénaı̈ssa, V. Robert, B. Aupetit-Faisant, A. Carayon, ... B. Swynghedauw, C. Delcayre	8	1999	8 🐜
🐜	Decreased Ferritin Levels in Brain in Parkinson's Disease 10 auth. D. Dexter, A. Carayon, M. Vidailhet, M. Ruberg, F. Agid, Y. Agid, ... A. Lees, F. R. Wells, P. Jenner, C. Marsden	8	1990	8 🐜
🐜	Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. 15 auth. G. Montalescot, F. Philippe, A. Ankri, E. Vicaut, E. Bearez, J. Poulard, D. Carrié, D. Flammang, Albert Dutoit, A. Carayon, ... C. Jardel, M. Chevrot, J. Bastard, F. Bigonzi, Daniel Thomas	8	1998	8 🐜
🐜	Prognostic value of plasma endothelin-1 in patients with chronic heart failure. 9 auth. F. Pousset, R. Isnard, Philippe Lechat, H. Kalotka, A. Carayon, G. Maistre, ... S. Escolano, Daniel Thomas, M. Komajda	7	1997	7 🐜
🐜	Cellular localization of endothelin‐1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells 7 auth. D. Rockey, L. Fouassier, John J. Chung, A. Carayon, P. Vallée, C. Rey, ... C. Housset	7	1998	7 🐜
🐜	Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. 9 auth. Y. Touitou, M. Fèvre, M. Lagoguey, A. Carayon, A. Bogdan, A. Reinberg, ... H. Beck, F. Cesselin, C. Touitou	7	1981	7 🐜
🐜	Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. 9 auth. P. Cacoub, R. Dorent, G. Maistre, P. Nataf, A. Carayon, C. Piette, ... P. Godeau, C. Cabrol, I. Gandjbakhch	7	1993	7 🐜
🐜	Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. 10 auth. A. Gackowski, R. Isnard, J. Golmard, F. Pousset, A. Carayon, G. Montalescot, ... J. Hulot, Daniel Thomas, W. Piwowarska, M. Komajda	6	2004	6 🐜
🐜	Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. 9 auth. P. Lim, J. Monin, M. Monchi, J. Garot, A. Pasquet, L. Hittinger, ... J. Vanoverschelde, A. Carayon, P. Guéret	6	2004	6 🐜
🐜	Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. 9 auth. F. Pousset, F. Masson, O. Chavirovskaia, R. Isnard, A. Carayon, Jean-Louis Golmard, ... Philippe Lechat, Daniel Thomas, M. Komajda	6	2000	6 🐜